These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 36852471

  • 1. Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease.
    Iwasa N, Kumazawa R, Nomura S, Shimizu M, Iwata M, Hara M, Kawabe M, Kobatake Y, Takashima S, Nishii N.
    J Vet Intern Med; 2023 Mar; 37(2):412-419. PubMed ID: 36852471
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of serum ionized magnesium concentration in dogs with myxomatous mitral valve disease.
    Kim OK, Kim K, Park S, Yang H, Kim H, Ro WB, Lee CM.
    J Vet Intern Med; 2024 Mar; 38(1):41-50. PubMed ID: 38064361
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.
    Yuchi Y, Suzuki R, Yasumura Y, Saito T, Teshima T, Matsumoto H, Koyama H.
    J Vet Intern Med; 2023 Mar; 37(3):856-865. PubMed ID: 36994902
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
    Khaki Z, Nooshirvani P, Shirani D, Masoudifard M.
    BMC Vet Res; 2022 Dec 23; 18(1):448. PubMed ID: 36564735
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of left atrial stiffness estimated using echocardiography in dogs with myxomatous mitral valve disease.
    Osuga T, Kuroda K, Morita T, Sasaki N, Nakamura K, Takiguchi M.
    J Vet Cardiol; 2023 Feb 23; 45():15-26. PubMed ID: 36608614
    [Abstract] [Full Text] [Related]

  • 6. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.
    Lee CM, Jeong DM, Kang MH, Kim SG, Han JI, Park HM.
    Am J Vet Res; 2017 Apr 23; 78(4):440-446. PubMed ID: 28345991
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease.
    Hong HJ, Oh YI, Park SM, An JH, Kim TH, Chae HK, Seo KW, Youn HY.
    BMC Vet Res; 2022 Jul 05; 18(1):261. PubMed ID: 35790968
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
    Vereb M, Atkins CE, Adin D, Blondel T, Coffman M, Lee S, Guillot E, Ward JL.
    J Vet Intern Med; 2024 Jul 05; 38(1):51-60. PubMed ID: 37909399
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Iron parameters analysis in dogs with myxomatous mitral valve disease.
    Kumiega E, A Kobak K, Noszczyk-Nowak A, Kasztura M.
    BMC Vet Res; 2024 May 18; 20(1):210. PubMed ID: 38762716
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of urinary neutrophil gelatinase-associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease.
    Troia R, Sabetti MC, Crosara S, Quintavalla C, Romito G, Mazzoldi C, Fidanzio F, Cescatti M, Bertazzolo W, Giunti M, Dondi F.
    J Vet Intern Med; 2022 Nov 18; 36(6):2053-2062. PubMed ID: 36196592
    [Abstract] [Full Text] [Related]

  • 12. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
    Reimann MJ, Häggström J, Møller JE, Lykkesfeldt J, Falk T, Olsen LH.
    J Vet Intern Med; 2017 Mar 18; 31(2):295-302. PubMed ID: 28132441
    [Abstract] [Full Text] [Related]

  • 13. Severity of myxomatous mitral valve disease in dogs may be predicted using neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio.
    Ku D, Chae Y, Kim C, Koo Y, Lee D, Yun T, Chang D, Kang BT, Yang MP, Kim H.
    Am J Vet Res; 2023 Jun 01; 84(6):. PubMed ID: 37024099
    [Abstract] [Full Text] [Related]

  • 14. Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.
    Zhou Q, Wu Z, Li L, Zhou H, Chen Y, Guo S, Guo Y, Ma X, Zhang J, Feng W, Cui X, Qiu C, Xu M, Deng G.
    J Proteomics; 2023 Jun 30; 282():104924. PubMed ID: 37146676
    [Abstract] [Full Text] [Related]

  • 15. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
    Galizzi A, Bagardi M, Stranieri A, Zanaboni AM, Malchiodi D, Borromeo V, Brambilla PG, Locatelli C.
    BMC Vet Res; 2021 Jan 07; 17(1):15. PubMed ID: 33413406
    [Abstract] [Full Text] [Related]

  • 16. Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.
    Druzhaeva N, Nemec Svete A, Ihan A, Pohar K, Domanjko Petrič A.
    J Vet Intern Med; 2021 Sep 07; 35(5):2112-2122. PubMed ID: 34236111
    [Abstract] [Full Text] [Related]

  • 17. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE, Falk T, Zois NE, Moesgaard SG, Häggström J, Pedersen HD, Ablad B, Nilsen HY, Olsen LH.
    J Vet Intern Med; 2012 Sep 07; 26(1):76-84. PubMed ID: 22151356
    [Abstract] [Full Text] [Related]

  • 18. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K, Kawamoto S, Osuga T, Morita T, Sasaki N, Morishita K, Ohta H, Takiguchi M.
    J Vet Intern Med; 2017 Mar 07; 31(2):316-325. PubMed ID: 28145607
    [Abstract] [Full Text] [Related]

  • 19. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
    Reimann MJ, Ljungvall I, Hillström A, Møller JE, Hagman R, Falk T, Höglund K, Häggström J, Olsen LH.
    Vet J; 2016 Mar 07; 209():113-8. PubMed ID: 26831162
    [Abstract] [Full Text] [Related]

  • 20. Inflammatory and immune variables as predictors of survival in dogs with myxomatous mitral valve disease.
    Cimerman M, Druzhaeva N, Nemec Svete A, Hajdinjak M, Pohar K, Ihan A, Domanjko Petrič A.
    BMC Vet Res; 2024 Sep 28; 20(1):431. PubMed ID: 39342325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.